Advances in Drug Development and Delivery: Innovation and Patient-Focus

Thursday, November 30, 2017 from 8:00 AM to 5:00 PM (EST)

CADDI & JLABS Toronto, Canada

register now button

Agenda:

8:00 am – 8:30 am | REGISTRATION & BREAKFAST
8:30 am – 8:45 am | WELCOME & INTRODUCTION
Prof. Christine Allen, Professor and GSK Chair in Pharmaceutics and Drug Delivery, University of Toronto
Breanne Halyk, Innovation Activation Manager, JLABS Canada

 

SMALL MOLECULE DRUG DEVELOPMENT CONSIDERATIONS

8:45 am – 9:15 am | DELIVERING THE “PROMISE OF R&D”
Dr. Cornell Stamoran, Founder, Catalent Institute
9:15 am – 10:00 am | FORMULATION TECHNOLOGIES TO OVERCOME ORAL BIOAVAILABILITY CHALLENGES OF SMALL MOLECULE DRUGS 
Mr. Stephen Tindal, Director, Science & Technology, Catalent Pharma Solutions
10:00 am – 10:15 am | BREAK 

10:15 am – 11:00 am | DESIGN OF AMORPHOUS SOLID DISPERSIONS FOR ENHANCING THE DELIVERY OF POORLY SOLUBLE DRUGS: EFFECT OF SOLUBLE VERSUS INSOLUBLE CARRIERS 
Prof. Ping Lee, Professor in Pharmaceutics and Drug Delivery, University of Toronto

11:00 am – 12:00 pm | PATIENT FOCUSED DOSE FORM DESIGN 
Dr. Cornell Stamoran, Founder, Catalent Institute
12:00 pm – 1:30 pm | NETWORKING LUNCH & MEET THE EXPERTS

 

LARGE MOLECULE DRUG DEVELOPMENT CONSIDERATIONS

Chair by Prof. Isabelle Aubert, Professor Laboratory Medicine and Pathobiology, University of Toronto

12:00 pm – 1:30 pm | REGISTRATION, NETWORKING LUNCH & MEET THE EXPERTS 
1:30 pm – 2:15 pm | EFFICIENT EXPRESSION OF COMPLEX PROTEINS IN MAMMALIAN CELLS 
Dr. Greg Bleck, Global Head R&D, Biologics, Catalent Biologics
2:15 pm – 3:00 pm | ANTIBODY-DRUG CONJUGATES 
Dr. David Rabuka, Global Head R&D, Chemical Biology, Catalent Biologics
3:00 pm – 3:15 pm | BREAK 
3:15 pm – 4:00 pm | THERAPEUTIC DISCOVERY USING SYNTHETIC ANTIBODY REPERTOIRES – Synthetic antibodies and immuno-oncology 
Dr. Jarrett Adams, Associate Director, Toronto Recombinant Antibody Centre 
4:00 pm – 5:00 pm | PANEL DISCUSSION 
Moderated by Prof. Isabelle Aubert
5:00 pm | CLOSING REMARKS 

Meet with a Catalent expert: Attendees have the opportunity to discuss their projects and challenges and learn about potential solutions in a 1-on-1 setting with a Catalent formulation or biologics expert. This is a complimentary opportunity for all attendees. Advanced scheduling is requested. Details to follow.